Sulindac sulfide selectively inhibits growth and induces apoptosis of human breast tumor cells by PDE5 inhibition, elevation of cGMP, and activation of PKG

Lignende værker

• β-catenin nuclear translocation in colorectal cancer cells is suppressed by PDE10A inhibition, cGMP elevation, and activation of PKG
  af: Lee, Kevin, et al.
  Udgivet: (2015)
• Sulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/β-catenin signaling
  af: Li, Nan, et al.
  Udgivet: (2013)
• Colon tumor cell growth inhibitory activity of sulindac sulfide and other NSAIDs is associated with PDE5 inhibition
  af: Tinsley, Heather N., et al.
  Udgivet: (2010)
• Inhibition of PDE5 by sulindac sulfide selectively induces apoptosis and attenuates oncogenic Wnt/β-catenin mediated transcription in human breast tumor cells
  af: Tinsley, Heather N., et al.
  Udgivet: (2011)
• A Novel Sulindac Derivative that Potently Suppresses Colon Tumor Cell Growth by Inhibiting cGMP Phosphodiesterase and β-Catenin Transcriptional Activity
  af: Whitt, Jason D., et al.
  Udgivet: (2012)